Literature DB >> 34375100

Drug-Polymer Interactions in Acetaminophen/Hydroxypropylmethylcellulose Acetyl Succinate Amorphous Solid Dispersions Revealed by Multidimensional Multinuclear Solid-State NMR Spectroscopy.

Andrea Pugliese1, Michael Toresco2, Daniel McNamara3, Dinu Iuga4, Anuji Abraham3, Michael Tobyn5, Lucy E Hawarden5, Frédéric Blanc1,6.   

Abstract

The bioavailability of insoluble crystalline active pharmaceutical ingredients (APIs) can be enhanced by formulation as amorphous solid dispersions (ASDs). One of the key factors of ASD stabilization is the formation of drug-polymer interactions at the molecular level. Here, we used a range of multidimensional and multinuclear nuclear magnetic resonance (NMR) experiments to identify these interactions in amorphous acetaminophen (paracetamol)/hydroxypropylmethylcellulose acetyl succinate (HPMC-AS) ASDs at various drug loadings. At low drug loading (<20 wt %), we showed that 1H-13C through-space heteronuclear correlation experiments identify proximity between aromatic protons in acetaminophen with cellulose backbone protons in HPMC-AS. We also show that 14N-1H heteronuclear multiple quantum coherence (HMQC) experiments are a powerful approach in probing spatial interactions in amorphous materials and establish the presence of hydrogen bonds (H-bond) between the amide nitrogen of acetaminophen with the cellulose ring methyl protons in these ASDs. In contrast, at higher drug loading (40 wt %), no acetaminophen/HPMC-AS spatial proximity was identified and domains of recrystallization of amorphous acetaminophen into its crystalline form I, the most thermodynamically stable polymorph, and form II are identified. These results provide atomic scale understanding of the interactions in the acetaminophen/HPMC-AS ASD occurring via H-bond interactions.

Entities:  

Keywords:  acetaminophen (paracetamol); amorphous solid dispersion; drug−polymer interactions; hydroxypropylmethylcellulose acetyl succinate (HPMC-AS); multidimensional NMR; solid-state NMR

Mesh:

Substances:

Year:  2021        PMID: 34375100      PMCID: PMC8424625          DOI: 10.1021/acs.molpharmaceut.1c00427

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


Introduction

Biopharmaceutical class II active pharmaceutical ingredients (APIs) (or drugs) exhibit poor bioavailability as a result of low aqueous solubility, accompanied by high biological membrane permeability.[1] API can exist either in the crystalline form, characterized by a three-dimensional (3D) structure in which molecules are packed in a regularly ordered repeating pattern, or amorphous form defined as an ensemble of molecules/units arranged randomly. The energy barrier required to break down the long-range structure means that crystalline systems can show low solubility and a low kinetic rate of dissolution. In amorphous systems, the lack of long-range order greatly enhances the apparent solubility and rate of dissolution.[2] From a thermodynamic viewpoint, the crystalline state is low energy and stable in contrast to the amorphous state, which is marked as high energy and unstable. The metastable nature of the amorphous state leads to the likelihood of physical instability and recrystallization promoted by external factors such as temperature or humidity.[3] Converting crystalline drugs to their amorphous counterpart is one of the most promising approaches in pharmaceutical material sciences to enhance APIs’ solubility and bioavailability. This strategy can be adopted only as long as a supersaturated solution of amorphous API can be maintained in the aqueous medium over time.[4] Amorphous solid dispersions (ASDs) have been extensively used to stabilize supersaturated solution of APIs, resulting in a general increase for oral bioavailability of poorly soluble drugs.[5−7] An ASD can be defined as a dispersion of one or more APIs in a solid-state inert carrier, usually an amorphous polymer,[8] and can be prepared by a range of manufacturing processes,[9] including spray drying,[10] spray freeze drying,[11] and hot melt extrusion.[12] Polymers such as poly(ethylene glycol) (PEG),[13] poly(ethylene oxide) (PEO),[14] poly(vinylpyrrolidone) (PVP),[15] poly(vinylpyrrolidone)–poly(vinyl acetate) (PVP–VA),[16] hydroxypropylmethylcellulose (HMPC),[17] and hydroxypropylmethylcellulose acetyl succinate (HPMC-AS)[18] have been successfully used in ASDs. In particular, HPMC-AS has recently been suggested as a promising solid matrix to formulate ASDs[19] due to its high glass transition temperature, Tg, in the order of 120 °C,[20] its amphiphilic nature arising from the existence of hydrophilic (e.g., acetyl, A) and hydrophobic (e.g., succinoyl, S) functional groups, and the capability to tune the A and S contents. It has been demonstrated that the polymer in ASDs plays a crucial role in stabilizing the amorphous form of the drug.[21] The choice of a suitable polymer to formulate a specific dispersion largely depends on several chemical–physical properties such as Tg, thermal stability, dissolution profile, performance in dissolving API, and capability to stabilize amorphous drugs.[22] These characteristics contribute to the stabilization of the ASD, which is due to the polymer’s antiplasticizing effect, reducing molecular mobility of the amorphous API, and the formation of specific API–polymer interactions.[21] Intermolecular interactions such as hydrogen bonding (H-bond), ionic forces, π–π, or electrostatic interactions are well established as the most significant interactions capable of stabilizing such dispersed systems[4] by inhibiting recrystallization phenomena in the amorphous matrix and preventing competitive API–API or polymer–polymer intramolecular interactions. Recently, the HPMC-AS polymer[23] has been widely used to prepare ASD due to its remarkable ability in stabilizing amorphous dispersions arising from the formation of strong API–HPMC-AS interactions.[24] The elucidation of the nature of the interaction between drugs and polymers and detecting recrystallized drugs in ASDs constitute some of the most significant challenges in pharmaceutical material sciences and require the exploitation of a range of characterization approaches, often combining powder X-ray diffraction (PXRD), thermal analysis, vibrational methods, and solid-state nuclear magnetic resonance (NMR) spectroscopy.[25,26] The PXRD patterns of amorphous solids result in broad diffuse scattering signals due to the lack of long-range order. Nevertheless, PXRD methods can provide significantly useful information on the residual crystalline content in ASDs, for example, during stability studies.[27] Thermal analysis, including differential scanning calorimetry (DSC) and temperature-modulated DSC (mDSC),[28] have been employed to estimate the residual crystallinity in amorphous systems[29] and are often used to determine Tg values and detect thermal events revealing crystallization and melting phenomena.[30] DSC therefore allows to detect miscibility of individual components of an ASD, where the observation of a single Tg indicates miscibility between API and the polymer.[31] Gordon–Taylor’s (GT) model[32] can be used to estimate the Tg of an ideal binary mixture (Tgmix) with significant deviations between predicted Tgmix and experimentally determined Tg providing useful information about the interactions between the components in the mixture,[4,25,26] as the presence of API–API or API–polymer interactions can affect the Tg value of the system, while agreement suggests systems with the absence of specific drug–polymer interactions. Furthermore, access to ASD stability can be also obtained using thermodynamic modeling and short- to medium-term physical stabilities of several API–polymer blend ASDs. These include acetaminophen–HPMC-AS dispersions under controlled temperature and relative humidity (RH) conditions which have been determined for the 20 and 40 wt % formulation to be up to 6 and 1 month(s), respectively.[33] This work highlights a reduction of stability of these systems with the increase of the polymer content and an increase of RH. A range of analytical methods including vibrational, Raman, Fourier-transform infrared (FT-IR) spectroscopy, and solid-state nuclear magnetic resonance (NMR) spectroscopies have been used to provide atomic scale information about solid dispersions. Raman applications include the measurements of crystallization rate[34] and mapping solid dispersions to identify and discriminate crystalline/amorphous domains.[35] FT-IR methods can be used to probe H-bonds for specific functional groups including hydroxyl, amino, and carbonyl groups when present in the API and/or the polymer molecular structure.[36] It has been demonstrated that when those functional groups are involved in H-bonding interactions, a simultaneous decrease in the stretching frequency and a widening of their absorption bands are observed due to smaller intermolecular distances between the donor–acceptor groups.[37] NMR spectroscopy has proved itself as a powerful technique by providing an invaluable source of both structural and dynamics information at the atomic scale thereby being demonstrated as one of the most powerful methods of characterization. In particular, in the field of pharmaceutical sciences,[38,39] NMR allows the determination of the structure of drugs[40] and polymers.[41] Recently, NMR has emerged as a robust approach in (pharmaceutical) amorphous dispersions to identity site-specific API–polymer intermolecular interactions from changes in chemical shift values.[42−45] For example, using one-dimensional (1D) and two-dimensional (2D) NMR experiments, electrostatic interactions and H-bonding were identified in amorphous posaconazole (POSA) dispersion in HPMC-AS and involved the POSA’s triazole and difluorophenyl ring moieties with some of the HPMC-AS’s substituent groups.[44] The presence of π–π aromatic packing interaction between POSA and HPMC-phthalate (HPMC-P) amorphous dispersion has also been highlighted.[44] Drug–polymer interactions in carbamazepine (CBZ) in HPMC, HPMC-A, and HPMC-S dispersions have also been established[42] and identified H-bonding between the CBZ’s −NH2 group with the acetyl moiety in HPMC-A and between both CBZ −NH2’s and carbonyl groups of the succinyl group in HPMC-S. This demonstrates the important role that both acetyl and succinyl groups of HPMC-AS could play in the formation of stable API–polymer connections. 2D NMR techniques that include homonuclear and heteronuclear correlation spectroscopy are widely used to detect intramolecular interaction by exploiting the homo- and heteronuclear through-space dipolar coupling between the nuclei. To increase the NMR sensitivity and hence to have access to high-resolution spectra and enabling proton detection, the use of ultrafast magic angle spinning (MAS) experiments, with frequency in the 50–110 kHz range, has also recently emerged. They enable fast characterization of pharmaceutical compounds and formulation by probing API–polymer interaction,[45] allowing NMR crystallography approaches[46] and understanding of low drug-loaded formulation.[47] The 14N–1H heteronuclear multiple-quantum coherence (HMQC)[48] experiment carried out at the high magnetic field and at ultrafast MAS conditions under direct 1H signal detection has been robustly employed to probe interactions in crystalline systems[49,50] and recently to highlight molecular association and interactions in amorphous dispersions.[51,52]14N–1H HMQC spectra were used to identify hydrogen bonding interaction in a nicotinamide palmitic acid cocrystal and acetaminophen–PVP amorphous dispersion.[50] The versatility of this experiment was demonstrated by providing information on the symmetry of the nitrogen environment and through-space proximities in paclitaxel-loaded polymer micelles amorphous formulations.[52] The 14N–1H HMQC experiment has however, to the best of our knowledge, not been used so far to investigate API–polymer interactions in HPMC-AS-based amorphous formulations. Here, we report the stability of amorphous acetaminophen in HPMC-AS ASDs at different drug loadings by identifying the presence of drug–polymer intramolecular interactions with multinuclear multidimensional NMR experiments. Acetaminophen (Figures and SI-1) is one of the most widely used API and its chemical–physical data, including melting point and solubility profiles, as well as crystalline data,[53,54] NMR spectra,[55] are largely known. The HPMC-AS polymer was chosen as excipient due to its excellent capacity to stabilize amorphous dispersion.[42,44] Morevoer, the lack of overlap between acetaminophen and polymer signals in the 13C NMR spectra allows monitoring of the changes in chemical shift and line width of the signals of both components to establish API–polymer interactions and crystalline/amorphous behavior. Multidimensional multinuclear MAS NMR data enable access to structural information in the solid state, highlighting the presence of API–polymer intermolecular interactions for ASDs with drug loading <20 wt % and providing useful indications of their stability. The approach also suggests the absence of API–polymer intermolecular interaction in the 40 wt % ASD and rather identifies signals corresponding to crystalline acetaminophen interacting with itself.
Figure 1

Chemical structure of (a) acetaminophen and (b) HPMC-AS polymer. HPMC-AS consists of a cellulose ring bonded with various R groups that include hydrogen, methyl (M), hydroxypropyl (P), acetyl (A), and succinoyl (S) groups. The wavy bond in the cellulose ring indicates that the cellulose ring can exist in two different cyclic hemiacetal configurations, called α- and β-glucopyranose, distinguishable from the different configurations of the anomeric carbon C1. The lettering and numbering are used for all NMR spectral assignments throughout.

Chemical structure of (a) acetaminophen and (b) HPMC-AS polymer. HPMC-AS consists of a cellulose ring bonded with various R groups that include hydrogen, methyl (M), hydroxypropyl (P), acetyl (A), and succinoyl (S) groups. The wavy bond in the cellulose ring indicates that the cellulose ring can exist in two different cyclic hemiacetal configurations, called α- and β-glucopyranose, distinguishable from the different configurations of the anomeric carbon C1. The lettering and numbering are used for all NMR spectral assignments throughout.

Experimental Section

Materials

ASDs were prepared using acetaminophen form I (99.5%) purchased from Spectrum Chemical Company and HPMC-AS polymer M grade obtained from Shin-Etsu Chemical Co. (lot # 6033060, M content = 23.4%, P content = 7.3%, A content = 8.8%, and S content = 11.2%). Sigma-Aldrich’s acetaminophen form I was used to carry out the PXRD analysis. The dipeptide β-AspAla was obtained from Bachem. All materials were used as received.

Synthesis of ASDs

General procedure of the preparation of ASDs: Gram-scale batches formulated at 10, 20, and 40 wt % of acetaminophen were manufactured using a custom-built small-scale spray dryer. Spray dry solution of acetaminophen and the polymer containing 2.5% solid (acetaminophen and HPMC-AS) were sprayed at 65–70 °C from acetone (80 mL) using heated nitrogen gas through a two-fluid spraying nozzle (2050 LC/64AC, Spraying Systems Co.). The ASD was then collected by filtration from the spray dryer and dried overnight in vacuo. ASDs were stored in a freezer kept at low temperature (−80 °C) to prevent API recrystallization. Synthesis of 10 wt % acetaminophen in HPMC-AS ASD: This formulation was prepared according to the general procedure highlighted above using acetaminophen (0.2 g, 1.3 mmol) and HPMC-AS (1.7 g). Synthesis of 20 wt % acetaminophen in HPMC-AS ASD: This formulation was prepared according to the general procedure highlighted above using acetaminophen (0.4 g, 2.7 mmol) and HPMC-AS (1.6 g). Synthesis of 40 wt % acetaminophen in HPMC-AS ASD: This formulation was prepared according to the general procedure highlighted above using acetaminophen (0.8 g. 5.3 mmol) and HPMC-AS (1.2 g).

PXRD Measurements

Laboratory PXRD data were collected using a PANalytical Empyrean diffractometer equipped with a high throughput transmission geometry, focusing mirror, 1/2° divergence, and antiscatter slits, 4 mm beam mask, 0.04° soller slits, with Cu Kα of 1.541874 Å. PXRD patterns were measured over the 2θ range 2–40° over 1 h.

Standard and Modulated DSC Measurements

DSC experiments were performed using a DSC Q1000 (TA Instruments, DE) system using TA-Tzero aluminum pans loaded with an amount of around 10 mg of the sample. Standard DSC analyses were carried out using a cool–heat–cool cycle method in which the sample was cooled to −15 °C and heated up to 160 °C with a ramp of 10 °C min–1, and then, after an isotherm of 5 min, a cool ramp of 20 °C min–1 was applied back down to −15 °C. mDSC experiments were carried out using a heating ramp of 2.5 °C min–1 with a modulation amplitude of 1.5 °C every 60 s.

Solid-State NMR Experiments

1H NMR spectra were recorded on a Bruker 800 MHz (18.8 T) Avance Neo NMR spectrometer using a Bruker 1.3 mm HX MAS probe or on a Bruker 850 MHz (20 T) Avance Neo spectrometer equipped with a Bruker 1.3 mm triple-resonance HXY MAS probe in the double resonance (DR) mode. All spectra were recorded under a MAS frequency of νr = 60 kHz. 1H pulses were carried out at a radio frequency (rf) field amplitude of 100 kHz. ASDs 1H spin-lattice relaxation times T1 were recorded at 18.8 T from saturation recovery experiments and fitted to a stretch exponential function of the form 1 – exp[−(τ/T1)α] in which τ is the variable delay and α the stretch factor ranging from 0.5 and 1. All 13C/15N cross-polarization (CP) and two-dimensional (2D) 1H–13C/15N CP heteronuclear correlation (HECTOR) experiments were performed on a Bruker 400 MHz (9.4 T) Avance III HD NMR spectrometer equipped with a Bruker 4 mm triple-resonance HXY MAS probe in the DR mode tuned to 1H and 13C or 15N at Larmor frequencies of 400.1, 100.6, and 40.5 MHz. 1H pulses and SPINAL-64 heteronuclear decoupling[56] during 13C/15N detection were carried out with an rf field amplitude of 83 kHz. All experiments were performed under a MAS frequency of νr = 12.5 kHz for 13C and 10 kHz for 15N and using a recycle delay of 1.3 × 1H T1s obtained as above (data at 9.4 T, not given). The Hartmann–Hahn[57] conditions for 13C CP were achieved using a 13C rf amplitude of around 45 kHz ramped to obtain maximum signal at a 1H rf field of 60 kHz, and for 15N CP, a 15N rf amplitude of 28 kHz ramped to obtain maximum signal at a 1H rf field of 50 kHz was used. A 2 ms contact time during 13C CP and optimized CP contact times of 1 ms for the amorphous material and 6 ms for the crystalline sample during 15N CP were used. ASD’s 1H spin-lattice relaxation times in the rotating frame (T1ρ) were obtained at 9.4 T, using a spin-lock pulse sequence through 13C detection via CP, at 1H frequencies of ω1/2π of 40 and 83 kHz and fitted to a stretch exponential function of the form exp[−(τ/T1ρ)β] (with β ranging between 0.2 and 1). 13C T1s were obtained at 9.4 T from 13C inversion recovery via CP experiments and fitted to an expression of the form exp[−(τ/T1)γ] (with γ ranging from 0.4 to 1). Frequency switched Lee–Goldberg (FSLG) homonuclear decoupling[58] during the 1H t1 evolution time in the 2D CP HETCOR spectra was obtained at an rf amplitude of 83 kHz and an offset of 60 kHz. Experimentally determined 1H scaling factors λexp for FSLG (as measured on l-alanine using the experimental conditions given above) were used to recover the full 1H chemical shifts δ(1H)MAS from the scaled-down apparent chemical shifts δ(1H)APP according to δ(1H)APP = λexpδ(1H)MAS that result from this decoupling. 14N–1H HMQC experiments were carried out using a Bruker 800 MHz (18.8 T) Avance Neo NMR spectrometer equipped with a Bruker 1.3 mm HX MAS probe tuned to 1H and 14N at 800.3 and 58.7 MHz, respectively, or using a Bruker 850 MHz (20.0 T) Avance Neo NMR spectrometer equipped with a Bruker 1.3 mm triple-resonance HXY MAS probe operating in the DR mode tuned to 1H and 14N at 850.2 and 61.4 MHz, respectively. Experiments were performed under a MAS frequency νr = 60 kHz. In the 14N–1H HMQC pulse sequence used, heteronuclear dipolar couplings were reintroduced via rotary resonance recoupling, R3,[59] on the n = 2 resonance condition,[48] using an x, −x phase inversion[60] of individual block lengths of one rotor period of 16.7 μs at an rf amplitude of 120 kHz (2 × MAS frequency). 1H and 14N pulses were performed at an rf amplitude of 100 and 72 kHz, respectively. HMQC spectra were processed after removal of the first few points in the free induction decay (FID) using a home-built macro running on TopSpin to reduce baseline distortion and residual t1 noise from the spectrum. 1H, 13C, and 15N spectra were externally referenced to the NH proton of the dipeptide β-AspAla at 8.0 ppm,[50] the tertiary carbon of adamantane at 29.45 ppm,[61] and to glycine at −347.2 ppm,[62] respectively. 14N shifts were referenced to solid NH4Cl at −341.3 ppm,[62] which has a cubic 14N site.[63] Magic angle calibrations were achieved by maximizing either the separation of NH3 and NH resonances of the dipeptide β-AspAla in the 14N–1H HMQC spectrum or the number of rotational resonances in the time domain of the 79Br FID of KBr. The errors associated with 1H, 13C, and 15N chemical shifts and 14N parameters are given in the respective tables. 1H T1ρ and 13C T1 fitting data were carried out using MATLAB R2017a. Deconvolution of the experimental spectra was carried out in TopSpin 4.0.5 using the solid line shape analysis routine.

Results and Discussion

PXRD Characterization

Acetaminophen exists in three polymorphic forms:[53,64,65] monoclinic form I (space group P21/a and the number of asymmetric units in the cell, Z′ = 1), which is the most thermodynamically stable form; orthorhombic form II (space group Pcab, Z′ = 1) polymorph, and a highly metastable form III (space group Pca21, Z′ = 2). Time-dependent PXRD pattern measurements (Figure ) on acetaminophen–HPMC-AS ASDs at 10 wt % (in dark blue), 20 wt % (in orange), and 40 wt % (in red) loadings were carried out over a 1-year period of exposure at room temperature (RT, around 20 °C) and ambient relative humidity (RH, ranging from 30 to 50%) to monitor the chemical stability of the systems and potential recrystallization phenomena. The diffraction patterns of the 10 wt % (in dark blue) ASD exhibit the typical broad signal of an amorphous material and the absence of Bragg peaks up to 1 year, indicating a strong tendency of this system to remain in the amorphous state. The 20 wt % ASD shows a typical broad signal of an amorphous material only up to 4 weeks at RT and ambient RH after which reflections from acetaminophen form I start to appear. This is in sharp contrast with the PXRD data in 40 wt % ASD that shows recrystallization after only 1 week and, interestingly, to a mixture of both acetaminophen form I and II polymorphs.
Figure 2

PXRD patterns of (a) simulated acetaminophen form I from CSD (refcode HXACAN01, brown dotted lines),[64] (b) experimental acetaminophen form I (brown full lines), and (c) simulated acetaminophen form II from CSD (refcode HXACAN23, light blue dotted lines).[64] Comparison of PXRD patterns of 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) for the acetaminophen–HPMC-AS ASDs at times of (d) less than 1 day, (e) 1 week, (f) 4 weeks, and (g) 1 year at RT (around 20 °C) and ambient RH (ranging from 30 to 50%). After 1 year, the 10 wt % ASD still shows an amorphous state, while in the 20 wt % traces of recrystallization to acetaminophen I is observed and further confirmed by the 13C CP HETCOR spectra (Figure SI-2). In 40 wt % ASD, acetaminophen forms I and II are detected after only 1 week.

PXRD patterns of (a) simulated acetaminophen form I from CSD (refcode HXACAN01, brown dotted lines),[64] (b) experimental acetaminophen form I (brown full lines), and (c) simulated acetaminophen form II from CSD (refcode HXACAN23, light blue dotted lines).[64] Comparison of PXRD patterns of 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) for the acetaminophen–HPMC-AS ASDs at times of (d) less than 1 day, (e) 1 week, (f) 4 weeks, and (g) 1 year at RT (around 20 °C) and ambient RH (ranging from 30 to 50%). After 1 year, the 10 wt % ASD still shows an amorphous state, while in the 20 wt % traces of recrystallization to acetaminophen I is observed and further confirmed by the 13C CP HETCOR spectra (Figure SI-2). In 40 wt % ASD, acetaminophen forms I and II are detected after only 1 week.

Thermal Characterization

The GT model was used to estimate the predicted Tgmix values of the acetaminophen–HPMC-AS dispersion at different drug loading wt % from the following expressionwhere w and Tg are the weight fractions and glass transition temperature of each component, respectively, and k a constant related to the density ρ (ρacetaminophen = 1.29 g cm–3, ρHPMC-AS = 1.28 g cm–3)[33] and given by Supporting information Table SI-1 summarizes Tgs for the individual components as well as the predicted and experimental Tgmix values obtained for the 10, 20, and 40 wt % ASDs with negative deviations from predicted Tgs represented in Figure . This demonstrates the nonideal drug–polymer mixture,[7] the negative deviations suggesting that intramolecular interactions between like species (drug–drug or polymer–polymer) dominate. However, importantly, this does not exclude the presence, to a lesser extent, of intramolecular drug–polymer interactions (see below).[66] Additionally, negative deviations can also be interpreted as being indicative of nonideal additivity of volume for the two components and points out of a likelihood of phase separation of the system.[67] The largest deviation is found for the 40 wt % solid dispersion and suggests that at, among the ASDs studied, recrystallization phenomena and phase separation occur more quickly in this formulation.
Figure 3

Tg values of acetaminophen–HPMC-AS dispersions obtained at different acetaminophen loadings in HPMC-AS polymer-based ASDs. Experimentally obtained values for the ASDs, individual component, and predicted values from the GT model based on eq are given in empty circles (○), filled circles (●), and solid line, respectively.

Tg values of acetaminophen–HPMC-AS dispersions obtained at different acetaminophen loadings in HPMC-AS polymer-based ASDs. Experimentally obtained values for the ASDs, individual component, and predicted values from the GT model based on eq are given in empty circles (○), filled circles (●), and solid line, respectively.

Solid-State NMR Data

Figure a compares the 13C CP MAS spectra of acetaminophen form I, HPMC-AS polymer, 10, 20, and 40 wt % ASDs. The spectrum of acetaminophen form I presents resonances at around 170 ppm for the carbonyl (CbI), 152–116 ppm for the aromatic carbons (CfI, CcI, CdI, CeI), and 24 ppm for the methyl carbon (CaI) (see Figure a and Table SI-2) (“I” indicates characteristic resonances for the acetaminophen form I) based on the previous literature.[68] The four peaks in the region 105–60 ppm in the spectrum of the HPMC-AS polymer (Figure b) can be attributed to the anomeric C1, C4, C2,3, and C5,10 carbons, while the shoulders at around 70 and 58 ppm correspond to C6,9 (CH2s) and C8 (methoxy group), and the three peaks in the aliphatic region to C16,17 (CH2 of the S group), C14 (CH3 of the A group), and C11 (methyl group of the P moiety). Deconvolution in the carbonyl region of the HPMC-AS polymer reveals two signals assigned to C15,18 (most shifted peak, S substituent the COs) and C13 (A’s CO).[69] The knowledge of the 13C assignment of both the drug and HPMC-AS polymer plays an important role in the identification of drug–polymer interactions in ASDs as this is largely based on the change in chemical shifts.[4,43] The 13C assignments for the 13C CP MAS NMR spectra of all ASDs, recorded at less than 1 day at RT/ambient RH, are based on the known spectra of HPMC-AS[69] and acetaminophen form I and II[68] (Table SI-2). In the spectra of the ASDs, signals assignable to the amorphous acetaminophen generally appear broader than in the crystalline form as expected from amorphization as the loss of crystallinity brings of a range of chemical environments present that are randomly distributed in the sample resulting in severe inhomogeneous line broadening.[43] The decreased resolution is evident from the absence of split signals of the aromatic carbons of acetaminophen (CdI and CeI), due to the lack of crystal packing, indicating the presence of amorphous acetaminophen. This is further confirmed by a significant shortening of 13C T1 values by up to 2 orders of magnitude from acetaminophen form I to the amorphous acetaminophen in the ASD (Table SI-3). Meanwhile, the 13C T1 values for HPMC-AS in the ASDs are slightly increased, presumably indicating an increase in rigidity when formulated and suggesting its co-binding in API–polymer interactions (see below). In addition, 13C NMR signals for CdI/CeI and quaternary carbons Cfa show a small difference in chemical shifts of 2–3 ppm vs acetaminophen form I (Table ). This suggests a structural change in the amorphous systems[43,45,70] attributed to crystalline API conversion to its amorphous form[71] and results from the absence of long-range 3D interactions (e.g., hydrogen bonding, π–π interactions) in the crystalline sample, resulting in variation of local electronic environments.
Figure 4

(a) 13C CP MAS spectra of crystalline acetaminophen form I (brown), HPMC-AS (black),[69] 10 wt % (dark blue), 20 wt % (orange), and 40 wt % acetaminophen–HPMC-AS ASDs (red) recorded at less than 1 day at RT/ambient RH. (b) Magnified view of the 190–160 ppm (carbonyl region) of all of the spectra. (c) 13C CP spectrum of the 40 wt % dispersion toward recrystallization after 1 week at RT/ambient RH. A magnified view of the aromatic region of this spectrum is given in Figure SI-3. For spectral identification, simulated spectra (dashed gray lines) and spectral deconvolution (gray lines) are also shown. The notations “I” and “II” indicate the characteristic resonances for the acetaminophen forms I and II, respectively, while the notation “a” indicates resonance that can be attributed to amorphous acetaminophen.

Table 1

Selected Significant Changes in 13C Chemical Shiftsa,b

signalacetaminophen form IHPMC-AS10 wt % ASD20 wt % ASD40 wt % ASDrecrystallized 40 wt % ASD
C15,18n.a.174174177176174.9
C13n.a.171172173173172.4
Cb169.7n.a.171171171169.8(I/II)
Cf152.2n.a.154154154153.8(II), 152.2(I)
Cc132.9n.a.131131131132.9(I), 130.76(II)
Cd123.3, 120.5n.a.121121121123.3(I), 120.5(I/II)
Ce116.3, 115.6n.a.116116116118.3(II), 115.7(I)

A comprehensive list of 13C chemical shifts is given in Table SI-2.

Values are given in ppm. The 13C chemical shifts of all assigned resonances are quoted within an accuracy of ±1 ppm due to the broad line widths associated with amorphous samples, except for the crystalline species where they are quoted at ±0.5 ppm. “I” and “II” indicate resonances belonging to acetaminophen form I and II, respectively.

(a) 13C CP MAS spectra of crystalline acetaminophen form I (brown), HPMC-AS (black),[69] 10 wt % (dark blue), 20 wt % (orange), and 40 wt % acetaminophen–HPMC-AS ASDs (red) recorded at less than 1 day at RT/ambient RH. (b) Magnified view of the 190–160 ppm (carbonyl region) of all of the spectra. (c) 13C CP spectrum of the 40 wt % dispersion toward recrystallization after 1 week at RT/ambient RH. A magnified view of the aromatic region of this spectrum is given in Figure SI-3. For spectral identification, simulated spectra (dashed gray lines) and spectral deconvolution (gray lines) are also shown. The notations “I” and “II” indicate the characteristic resonances for the acetaminophen forms I and II, respectively, while the notation “a” indicates resonance that can be attributed to amorphous acetaminophen. A comprehensive list of 13C chemical shifts is given in Table SI-2. Values are given in ppm. The 13C chemical shifts of all assigned resonances are quoted within an accuracy of ±1 ppm due to the broad line widths associated with amorphous samples, except for the crystalline species where they are quoted at ±0.5 ppm. “I” and “II” indicate resonances belonging to acetaminophen form I and II, respectively. Furthermore, and more importantly, the carbonyl carbons of the A and S units (C15,18 and C13) in the ASDs appear to be sensitive to the amount of amorphous acetaminophen in the ASDs as a slight change in chemical shifts vs HPMC-AS to a higher frequency is observed (Figure b and Table ), as shown by the deconvoluted signals for the 190–160 ppm region of the spectra that assumed the presence of three carbonyl signals Cb, C13,15, and C18 “three signals model” and supported by residual spectra (Figure SI-4). These shifts are ascribed to API–polymer intramolecular interaction in ASDs and detect molecular association via H-bonding in dispersions,[31,72,73] as previously observed in the posaconazole (POSA) and HPMC-AS ASD.[44] The 13C CP MAS NMR spectrum of the 40 wt % ASD was also recorded after 1 week under ambient conditions (Figure c) and shows significant differences with the one obtained at less than 1 day at RT/ambient RH. The spectrum exhibits a number of additional and sharper peaks as well as a lengthening of the 1H T1’s (Table SI-4), indicating the presence of crystalline acetaminophen arising from fast recrystallization from the ASDs. The resonances observed in Figure c (a magnified view of the aromatic region of this spectrum is given in Figure SI-3) indicate the presence of signals that can be attributed to both acetaminophen form I (Figure a, brown) and II[68] as anticipated from the PXRD data (Figure ). The presence of signals attributable to the two polymorphs of acetaminophen in 40 wt % ASD strongly indicates the instability of this dispersion toward recrystallization and could be reasonably explained by the lack of any interaction between acetaminophen and HPMC-AS, as predicted by the significant negative deviation from the GT model (Figure ). Figure a compares the 15N CP MAS NMR spectra of acetaminophen form I, 10 and 20 wt % amorphous acetaminophen in HPMC-AS solid dispersion, which show one signal assignable to the acetaminophen NH amide group (Figure a). This peak resonates at −243 ppm and is fairly narrow (full-width-at-half maximum, FWHM of 26 Hz), which is consistent with the literature data for acetaminophen form I,[68] while the signal appears at −247 ppm for both 10 and 20 wt % ASDs and is significantly broader (FWHM of 240–260 Hz). The change in the 15N chemical shift and broadening of the 15N spectra observed between crystalline and amorphous species suggests a different hydrogen-bonding network and intramolecular interactions (Table ).[42,45,74] The 15N CP spectrum of the 40 wt % ASD shows a single resonance at −243 ppm (FWHM of 24 Hz) at the same chemical shift for crystalline form I and likely arises from acetaminophen that underwent recrystallization during data acquisition. Although acetaminophen forms I and II in the 40 wt % ASD have been observed in both PXRD and 13C NMR data, the two expected 15N signals are not resolved at 9.4 T, likely due to their very similar chemical shift values only separated by 0.4 ppm.[68]
Figure 5

(a) 15N CP MAS spectra of crystalline acetaminophen form I (brown), 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) acetaminophen–HPMC-AS ASDs. (b) Quantitative 1H spectra of crystalline acetaminophen form I (brown), HPMC-AS (black), 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) acetaminophen HPMC-AS ASDs after recrystallization. 1H signal assignment is based on the 13C and 15N CP HETCOR experiments in Figures a and SI-5, respectively. Magnified views of both 15N CP and 1H spectra can be found in Figures SI-6 and SI-7, respectively.

Table 2

Experimental 15N Isotropic Chemical Shifts δiso(15N), 14N Shifts δiso(14N), 14N Quadrupolar-Induced Shifts δisoQ(14N), and Quadrupolar Products PQ

sampleδiso(15N)aδiso(14N)aδisoQ(14N)aPQb
acetaminophen form I[51]c–244–1251192.5
10 wt % ASDc–247–751722.9
20 wt % ASDd–247–801672.9
recrystallized 40 wt % ASDc–243–671762.9

Shifts are given in ppm. δiso(15N) values are obtained from the peak positions in the 15N CP MAS spectra (with an associated error of ±1 ppm), while δiso(14N) values represent the center of gravity of the 14N line shape extracted from the 14N–1H HMQC spectra (with an associated error of ±5 ppm). Magnetic field-dependent 14N shifts quoted in the table are given for 20 T.

PQ values are given in MHz, with an estimated error of ±0.1 MHz, and obtained from eq .

Experimental data obtained at 20 T.

Experimental data obtained at 18.8 T (Table SI-5) and quoted at 20 T.

(a) 15N CP MAS spectra of crystalline acetaminophen form I (brown), 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) acetaminophen–HPMC-AS ASDs. (b) Quantitative 1H spectra of crystalline acetaminophen form I (brown), HPMC-AS (black), 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) acetaminophen HPMC-AS ASDs after recrystallization. 1H signal assignment is based on the 13C and 15N CP HETCOR experiments in Figures a and SI-5, respectively. Magnified views of both 15N CP and 1H spectra can be found in Figures SI-6 and SI-7, respectively.
Figure 6

13C CP HETCOR spectra of HPMC-AS (black), 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) acetaminophen HPMC-AS ASD recorded with a contact time of (a) 50 μs and (b) 2 ms. Correlations were used for 1H spectral assignments. Top: 13C CP MAS spectra at a contact time of 2 ms. Left: 1H MAS NMR spectra. Internal projections are shown in dotted lines. The 13C CP MAS NMR spectrum of acetaminophen form I is also given (brown). In panel (a), the dashed lines are used to highlight correlations used for 1H assignment. For clarity, the correlation peaks for the polymer are only highlighted for the polymer’s HETCOR in panel ((a), black). In panel (b), the dashed lines denote the carbon signal involved in API–polymer interaction or API–API interaction for the 40 wt % dispersion, while the shaded sections in the spectra mark the cross-correlation peaks that show the API–polymer interactions. Figure SI-8 in the Supporting Information shows a magnified view of the 13C region at around 110–200 ppm, highlighting the API–polymer interactions.

Shifts are given in ppm. δiso(15N) values are obtained from the peak positions in the 15N CP MAS spectra (with an associated error of ±1 ppm), while δiso(14N) values represent the center of gravity of the 14N line shape extracted from the 14N–1H HMQC spectra (with an associated error of ±5 ppm). Magnetic field-dependent 14N shifts quoted in the table are given for 20 T. PQ values are given in MHz, with an estimated error of ±0.1 MHz, and obtained from eq . Experimental data obtained at 20 T. Experimental data obtained at 18.8 T (Table SI-5) and quoted at 20 T. The 1H MAS NMR spectrum (Figure b) of acetaminophen form I, obtained under a high magnetic field (>18.8 T) and very fast MAS frequency (>50 kHz), shows fairly resolved resonances at around 9.0, 7.9, 6.7, 5.7, and 1.1 ppm assigned to −NH and −OH groups, aromatic protons (HdI and HeI), and methyl groups, respectively. In the HPMC-AS spectrum, the three main peaks and the peak at 1.1 ppm can be assigned to H1, H2,3,5,10, H16,17, and H11,14, respectively, while spectral deconvolution reveals additional signals at 3.9, 3.0, and 2.5 ppm that are assigned to H6,9, H8, and H4, respectively. Due to possible exchange phenomena, the H7, −OH (hydroxypropyl substituent group), and the −CO2H (succinoyl moiety) proton signals (Figure ) are not observed in the 1D and 13C CP HETCOR spectra. The 1H spectra of HPMC-AS and all three ASDs (Figure b) are assigned from correlations observed in the 13C CP HETCOR spectra recorded at a short contact time (Figure a), 15N CP HETCOR spectrum of the 20 wt % (Figure SI-5), and known 1H chemical shifts. The 1H spectra of the ASDs (Figure b) show a cluster of signals around 5 and 1 ppm, corresponding to HPMC-AS, as well as additional resonances for the acetaminophen. As summarized in Table , in the 10 and 20 wt % ASDs, the aromatic proton signals (Hda and Hea) are deshielded with respect to the crystalline counterpart, the small difference observed being typical of amorphization processes.[71] Finally, the Hga and Hha signals merged into a single broad signal centered at 8.5 ppm, which correlates strongly with the 15N signal as revealed by the 15N CP HETCOR spectrum (Figure SI-5), potentially confirming the absence of deprotonation. It has been demonstrated that the deprotonation effect, promoted by the solvent during the spray dry process, might impact API–polymer interactions.[45] It is well known that evaluation of the length scale of spin diffusion allows the degree of mixture miscibility to be determined by recording the 1H relaxation times of all components.[75−78]1H T1 and T1ρ values have therefore been measured for the API and polymer in the ASD (Tables SI-4 and SI-6) and revealed that, for the 20 wt % formulation, they are similar (e.g., 1H T1 values for Hda and H1 are 1.7 ± 0.2 and 1.9 ± 0.3 s, respectively, and 1H T1ρ (Hda) = 3.8 ± 1.1 ms ≈ 1H T1ρ (H1) = 4.4 ± 0.3 ms at a spin-lock frequency of 40 kHz), indicating that in the 2–5 nm length scale,[79] there is miscibility in the acetaminophen–HPMC-AS ASD. In contrast, significantly different 1H T1 and T1ρ values are obtained for the recrystallized 40 wt % dispersion (Table SI-6), suggesting that phase separation phenomena occur in a domain size larger than 20–50 nm.[79]
Table 3

Significant Changes Observed in the 1H Chemical Shifts for Selected Protonsa

signalacetaminophen form I10 wt % ASD20 wt % ASDrecrystallized 40 wt % ASD
Hh9.08.58.59.0(I/II)
Hg7.98.58.57.9(I/II)
Hd6.77.47.47.2(I/II), 5.7(I/II)
He5.76.86.86.8(II), 5.7(I)

Values are given in ppm. A comprehensive list of 1H chemical shifts can be found in Table SI-7. The associated error with the chemical shift values is ±0.2 ppm.

13C CP HETCOR spectra of HPMC-AS (black), 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) acetaminophen HPMC-AS ASD recorded with a contact time of (a) 50 μs and (b) 2 ms. Correlations were used for 1H spectral assignments. Top: 13C CP MAS spectra at a contact time of 2 ms. Left: 1H MAS NMR spectra. Internal projections are shown in dotted lines. The 13C CP MAS NMR spectrum of acetaminophen form I is also given (brown). In panel (a), the dashed lines are used to highlight correlations used for 1H assignment. For clarity, the correlation peaks for the polymer are only highlighted for the polymer’s HETCOR in panel ((a), black). In panel (b), the dashed lines denote the carbon signal involved in API–polymer interaction or API–API interaction for the 40 wt % dispersion, while the shaded sections in the spectra mark the cross-correlation peaks that show the API–polymer interactions. Figure SI-8 in the Supporting Information shows a magnified view of the 13C region at around 110–200 ppm, highlighting the API–polymer interactions. Values are given in ppm. A comprehensive list of 1H chemical shifts can be found in Table SI-7. The associated error with the chemical shift values is ±0.2 ppm. Through-space 13C CP HETCOR experiments recorded at a longer contact time (in the range of ms) allow observation of acetaminophen–polymer interactions with correlation signals providing direct evidence of intermolecular drug polymer interactions. The corresponding 13C CP HETCOR spectra of both 10 and 20 wt % ASD identified correlation signals between peaks in 13C at 120–150 ppm corresponding to acetaminophen with 1H at 3 ppm (shaded signals in Figure b). These spatial correlations, detected via the strong 13C–1H heteronuclear dipolar coupling due to the rigid protons on the cellulose ring, cannot be ascribed to intramolecular correlations within acetaminophen due to the absence of 1H signals at this shift (Figure b) but rather an intermolecular acetaminophen–HPMC-AS interaction involving the aromatic carbons of acetaminophen with the backbone cellulose ring’s protons of the polymer. In sharp contrast, the 13C CP HETCOR spectrum of 40 wt % ASD identifies correlated signals corresponding to crystalline acetaminophen interacting with itself, as shown by the shaded signals in Figure b (no 2D correlation is observed for the broader shoulders of the 1D spectrum likely due to the poor signal-to-noise ratio in the HETCOR of the minor amorphous acetaminophen species). This suggests the absence of acetaminophen–HPMC-AS intramolecular interaction and indicates a two-phase immiscible system in which API–API interactions dominate, in good agreement with GT predictions, the presence of acetaminophen recrystallization and validating 1H relaxation data (see above), thereby confirming the instability of this ASD at the atomic level. 14N–1H HMQC experiments were then deployed under optima conditions of high magnetic field and very fast MAS frequency to establish the involvement of the amide nitrogen in the intermolecular interactions in these ASDs. 14N is a high abundance spin (99.6%) but due to its low gyromagnetic ratio (1.93 × 107 rad T–1 s–1) and spin quantum number I = 1, 14N has low sensitivity and exhibits quadrupole interaction, leading to a significant signal broadening. For these reasons, the direct detection of the 14N signal in the solid-state represents a challenge. The development of indirectly detected 14N via 1H as for example via 2D 14N–1H HMQC experiments at high magnetic field and very fast MAS frequency has enabled the solving of this challenge, establishing this approach as a promising methodology for identifying H-bonding between components in pharmaceutical systems.[51,52,80] The corresponding 14N–1H HMQC experiments for the 10 and 20 wt % ASDs (Figure ) identify the presence of correlation between the acetaminophen 14Na signal with the −OCH3 methoxy group (H8) of the polymer at 3 ppm and highlight H-bonding between this amide donor and oxygen acceptor. In the spectra, no correlation between the NH group of paracetamol and the protons of the substituent groups P, A, and S (Figure ) was identified, thus excluding the involvement of these groups in the formation of the H-bond between API and the polymer.
Figure 7

14N–1H HMQC experiments of 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) acetaminophen HPMC-AS ASDs obtained at a MAS frequency of 60 kHz. Data for 10/40% and 20 wt % were collected at 20 and 18.8 T, respectively. Spectra were recorded with recoupling times of 133.6 μs (10 wt % ASD, 8 rotor periods), 66.8 μs (20 wt % ASD, 4 rotor periods), and 801.6 μs (40 wt % ASD, 48 rotor periods). The deconvoluted 1H spectra of HPMC-AS under the same condition are also given in black. Spectra on the left of the 2D HMQC are the 14N slices extracted at the indicated 1H chemical shifts in dashed black lines.

14N–1H HMQC experiments of 10 wt % (dark blue), 20 wt % (orange), and 40 wt % (red) acetaminophen HPMC-AS ASDs obtained at a MAS frequency of 60 kHz. Data for 10/40% and 20 wt % were collected at 20 and 18.8 T, respectively. Spectra were recorded with recoupling times of 133.6 μs (10 wt % ASD, 8 rotor periods), 66.8 μs (20 wt % ASD, 4 rotor periods), and 801.6 μs (40 wt % ASD, 48 rotor periods). The deconvoluted 1H spectra of HPMC-AS under the same condition are also given in black. Spectra on the left of the 2D HMQC are the 14N slices extracted at the indicated 1H chemical shifts in dashed black lines. Importantly, this 14N signal correlating with H8 does not correspond to the same proton (Hha) identified via 15N CP HECTOR that established the NH correlation within acetaminophen (Figure SI-5) and suggests longer-range interactions. We note that this interaction for the 10 and 20 wt % amorphous dispersions was identified using short recoupling times of 133.6 and 66.8 μs, respectively, suggesting a closer contact between acetaminophen and HPMC-AS in those systems than in crystalline acetaminophen, which is consistent with the previous work in the amorphous formulation.[52] It is proposed that this H-bonding interaction is dominant to stabilize acetaminophen in its amorphous form in these ASDs. In contrast to the 10 and 20 wt % ASDs, the 14N–1H HMQC spectrum for the 40 wt % ASD clearly exhibits correlations between the 14N and 1H (HhI/II, HeII/HdI/II, and HaI/II) signals within acetaminophen and no correlation to the HPMC-AS polymer, confirming the absence of acetaminophen–HPMC-AS interactions at this high drug loading. The API–API H-bonding interaction was found at significantly longer recoupling times, reasonably indicating a longer distance between the packed acetaminophen molecules in the crystal structure compared to the API–polymer distance in amorphous systems, as illustrated previously.[50] For both the 10 and 20 wt % amorphous dispersions, the correlation signals in the 13C CP HETCOR experiments carried out at long contact times (Figure b) and 14N–1H HMQC spectra at short recoupling times (Figure ) highlight intermolecular amorphous drug–polymer H-bonding interactions (Figure ).
Figure 8

Schematic representation of the interactions that have been experimentally identified in this work. For dispersions with a drug loading of <20 wt %, spatial proximity (---) and H-bond (≣) were identified between the API and the polymer. The acetaminophen and HPMC-AS molecules are given in light blue and black, respectively.

Schematic representation of the interactions that have been experimentally identified in this work. For dispersions with a drug loading of <20 wt %, spatial proximity (---) and H-bond (≣) were identified between the API and the polymer. The acetaminophen and HPMC-AS molecules are given in light blue and black, respectively. The experimental 14N shifts for the observed signals in Figure and the 15N isotropic chemical shifts obtained in the 15N CP experiments (Figure a) for the 10 and 20 wt % ASDs are listed in Table . The differences in shifts between 14N and 15N are due to the 14N isotropic second-order quadrupolar shift, which is given by eq and allows the determination of the quadrupolar product PQ from eq (50)where ν0 is the 14N Larmor frequency. PQ depends on the quadrupolar coupling constant CQ and asymmetry parameter ηQ, as expressed by eq A significant difference of around 180–190 ppm between 15N isotropic chemical shift and 14N shift is observed (Table ) in the acetaminophen HPMC-AS ASD. This is attributed to the isotropic second-order quadrupolar shift being sensitive to the presence of the H-bond, as previously observed in the 50 wt % acetaminophen–PVP solid dispersion that extracted a δisoQ(14N) value of around 184 ppm.[51] This data further supports the presence of acetaminophen HPMC-AS H-bond in the dispersions with drug loading <20% wt and acetaminophen–acetaminophen H-bond interaction in the recrystallized 40% ASD. These are stabilizing interactions that can be imputed in the understanding of the stability of the amorphous acetaminophen–HPMC-AS solid dispersions. Interestingly, the main stabilizing interaction that has been identified in this work is H-bonding between the acetaminophen’s amide group with the OCH3 proton (H8) of the HPMC-AS methyl substituent (M), likely due to the small steric hindrance of this substituent vs the others (Figure ). This is an unexpected finding given that the acetyl and succinoyl groups in HPMC-AS have been previously suggested to be responsible for the formation of API–polymer H-bonding and contribute to the formation of stabilizing interactions.[42]

Conclusions

Molecular interactions in acetaminophen–HPMC-AS solid dispersion at 10, 20, and 40 wt % drug loadings were identified by combining time-dependent PXRD with multidimensional multinuclear NMR experiments. The presence of chemical shift differences in 1D 1H, 13C, and 15N CP MAS NMR spectra between crystalline and amorphous acetaminophen suggests a strong structural perturbation in the amorphous species and can be potentially rationalized by the presence of H-bonding interactions between acetaminophen and the polymer. 13C CP HETCOR exploiting strong 13C–1H dipolar coupling highlighted spatial interaction between the acetaminophen’s aromatic protons with the polymer’s cellulose ring protons in the 10 and 20 wt % ASDs. This interaction was further unequivocally confirmed by 14N–1H HMQC experiments that identify H-bond interactions between the NH of acetaminophen and the OCH3 proton of the HPMC-AS methyl substituent. The presence of this type of drug/polymer interaction in amorphous systems is of crucial importance as it stabilizes the amorphous dispersions. No acetaminophen–HPMC-AS interactions were found in the 40 wt % dispersion, further validated from 1H relaxation data, indicating the instability of this system and its tendency to recrystallize on a short timescale.
  58 in total

1.  Crystal structure determination of the elusive paracetamol Form III.

Authors:  Marc-Antoine Perrin; Marcus A Neumann; Hagit Elmaleh; Lionel Zaske
Journal:  Chem Commun (Camb)       Date:  2009-04-27       Impact factor: 6.222

Review 2.  Evaluation of amorphous solid dispersion properties using thermal analysis techniques.

Authors:  Jared A Baird; Lynne S Taylor
Journal:  Adv Drug Deliv Rev       Date:  2011-08-04       Impact factor: 15.470

3.  Identifying the intermolecular hydrogen-bonding supramolecular synthons in an indomethacin-nicotinamide cocrystal by solid-state NMR.

Authors:  Keisuke Maruyoshi; Dinu Iuga; Oleg N Antzutkin; Amjad Alhalaweh; Sitaram P Velaga; Steven P Brown
Journal:  Chem Commun (Camb)       Date:  2012-10-01       Impact factor: 6.222

4.  Hydrogen Bonding Interactions in Amorphous Indomethacin and Its Amorphous Solid Dispersions with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl acetate) Studied Using (13)C Solid-State NMR.

Authors:  Xiaoda Yuan; Tian-Xiang Xiang; Bradley D Anderson; Eric J Munson
Journal:  Mol Pharm       Date:  2015-11-12       Impact factor: 4.939

5.  Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.

Authors:  Yang Song; Xinghao Yang; Xin Chen; Haichen Nie; Stephen Byrn; Joseph W Lubach
Journal:  Mol Pharm       Date:  2015-01-28       Impact factor: 4.939

Review 6.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview.

Authors:  Dwayne T Friesen; Ravi Shanker; Marshall Crew; Daniel T Smithey; W J Curatolo; J A S Nightingale
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

7.  Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.

Authors:  Fumié Tanno; Yuichi Nishiyama; Hiroyasu Kokubo; Sakaé Obara
Journal:  Drug Dev Ind Pharm       Date:  2004-01       Impact factor: 3.225

8.  Solid state nuclear magnetic resonance studies of hydroxypropylmethylcellulose acetyl succinate polymer, a useful carrier in pharmaceutical solid dispersions.

Authors:  Andrea Pugliese; Lucy E Hawarden; Anuji Abraham; Michael Tobyn; Frédéric Blanc
Journal:  Magn Reson Chem       Date:  2020-02-03       Impact factor: 2.447

9.  Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation.

Authors:  Zedong Dong; Ashish Chatterji; Harpreet Sandhu; Duk Soon Choi; Hitesh Chokshi; Navnit Shah
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

10.  The Use of Binary Polymeric Networks in Stabilizing Polyethylene Oxide Solid Dispersions.

Authors:  David S Jones; Yiwei Tian; Shu Li; Tao Yu; Osama A Abu-Diak; Gavin P Andrews
Journal:  J Pharm Sci       Date:  2016-08-09       Impact factor: 3.534

View more
  1 in total

1.  Optimisation of 1H PMLG homonuclear decoupling at 60 kHz MAS to enable 15N-1H through-bond heteronuclear correlation solid-state NMR spectroscopy.

Authors:  Jacqueline Tognetti; W Trent Franks; Józef R Lewandowski; Steven P Brown
Journal:  Phys Chem Chem Phys       Date:  2022-08-31       Impact factor: 3.945

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.